Physicians at the Arrhythmia and Ablation Center at Florida Hospital continue to monitor new treatments for atrial fibrillation. Clinical trials include Dabigatran, which has been used to treat thrombosis and Lovaza, which is a prescription medication based on Omega-3 fatty acids that is currently used to lower triglycerides.